The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
The impact of comprehensive geriatric assessment interventions on tolerance to chemotherapy in older people
Open accessAbstract
BACKGROUND: Although comorbidities are identified in routine oncology practice, intervention plans for the coexisting needs of older people receiving chemotherapy are rarely made. This study evaluates the impact of geriatrician-delivered comprehensive geriatric assessment (CGA) interventions on chemotherapy toxicity and tolerance for older people with cancer. METHODS: Comparative study of two cohorts of older patients (aged 70+ years) undergoing chemotherapy in a London Hospital. The observational control group (N=70, October 2010-July 2012) received standard oncology care. The intervention group (N=65, September 2011-February 2013) underwent risk stratification using a patient-completed screening questionnaire and high-risk patients received CGA. Impact of CGA interventions on chemotherapy tolerance outcomes and grade 3+ toxicity rate were evaluated. Outcomes were adjusted for age, comorbidity, metastatic disease and initial dose reductions. RESULTS: Intervention participants undergoing CGA received mean of 6.2±2.6 (range 0-15) CGA intervention plans each. They were more likely to complete cancer treatment as planned (odds ratio (OR) 4.14 (95% CI: 1.50-11.42), P=0.006) and fewer required treatment modifications (OR 0.34 (95% CI: 0.16-0.73), P=0.006). Overall grade 3+ toxicity rate was 43.8% in the intervention group and 52.9% in the control (P=0.292). CONCLUSIONS: Geriatrician-led CGA interventions were associated with improved chemotherapy tolerance. Standard oncology care should shift towards modifying coexisting conditions to optimise chemotherapy outcomes for older people.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., Filiberti, A., Flechtner, H., Fleishman, S. B., Haes, J. C. J. M. D., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.5.365 · Cited by 16,005
Comprehensive geriatric assessment: a meta-analysis of controlled trials
Stuck, A. E., Siu, A. L., Wieland, G. D., Rubenstein, L. Z., & Adams, J. (1993) · The Lancet · doi:10.1016/0140-6736(93)92884-v · Cited by 1,974 · cited 4×
“Despite the robust evidence base for CGA in other settings (Stuck et al, 1993; Elliot et al, 1996; Vidan et al, 2005; Harari et al, 2007; Ellis et al, 2011a, b; Gonzalez Montalvo et al, 2011), this has been little applied to the chemotherapy setting.”
BackgroundInfluentialPredicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study
Hurria, A., Togawa, K., Mohile, S. G., Owusu, C., Klepin, H. D., Gross, C. P., Lichtman, S. M., Gajra, A., Bhatia, S., Katheria, V., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.34.7625 · Cited by 1,841 · cited 3×
“Some report its utility in predicting chemotherapy toxicity (Extermann et al, 2011; Hurria et al, 2011).”
BackgroundResultWildiers, H., Heeren, P., Puts, M., Topinkova, E., Janssen-Heijnen, M. L. G., Extermann, M., Falandry, C., Artz, A., Brain, E., Colloca, G., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.54.8347 · Cited by 1,831
Extermann, M., Boler, I., Reich, R. R., Lyman, G. H., Brown, R. H., DeFelice, J., Levine, R. M., Lubiner, E. T., Reyes, P., Schreiber, F. J., et al. (2012) · Cancer · doi:10.1002/cncr.26646 · Cited by 1,143
Comprehensive geriatric assessment for older adults admitted to hospital
Ellis, G., Whitehead, M. A., O'Neill, D., Langhorne, P., & Robinson, D. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006211.pub2 · Cited by 1,114
Ellis, G., Whitehead, M. A., Robinson, D., O'Neill, D., & Langhorne, P. (2011) · BMJ · doi:10.1136/bmj.d6553 · Cited by 1,068
Comprehensive geriatric assessment for older patients with cancer
Extermann, M., & Hurria, A. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.10.6559 · Cited by 875
Developing a cancer‐specific geriatric assessment: A feasibility study
Hurria, A., Gupta, S., Zauderer, M., Zuckerman, E. L., Cohen, H. J., Muss, H., Rodin, M., Panageas, K. S., Holland, J. C., Saltz, L., et al. (2005) · Cancer · doi:10.1002/cncr.21422 · Cited by 623
Rubenstein, L. Z., Stuck, A. E., Siu, A. L., & Wieland, D. (1991) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1991.tb05927.x · Cited by 597
Vidán, M., Serra, J. A., Moreno, C., Riquelme, G., & Ortiz, J. (2005) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2005.53466.x · Cited by 549
Caillet, P., Canoui-Poitrine, F., Vouriot, J., Berle, M., Reinald, N., Krypciak, S., Bastuji-Garin, S., Culine, S., & Paillaud, E. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.0664 · Cited by 426
Harari, D., Hopper, A., Dhesi, J., Babic-Illman, G., Lockwood, L., & Martin, F. (2007) · Age and Ageing · doi:10.1093/ageing/afl163 · Cited by 387
Self-citationMcCorkle (2000) · doi:10.1111/j.1532-5415.2000.tb03886.x · Cited by 321
Mohile, S. G., Bylow, K., Dale, W., Dignam, J., Martin, K., Petrylak, D. P., Stadler, W. M., & Rodin, M. (2007) · Cancer · doi:10.1002/cncr.22495 · Cited by 253
Can older cancer patients tolerate chemotherapy?: A prospective pilot study
Chen, H., Cantor, A., Meyer, J., Beth Corcoran, M., Grendys, E., Cavanaugh, D., Antonek, S., Camarata, A., Haley, W., Balducci, L., et al. (2003) · Cancer · doi:10.1002/cncr.11110 · Cited by 203
Does a Geriatric Oncology Consultation Modify the Cancer Treatment Plan for Elderly Patients?
Girre, V., Falcou, M.-C., Gisselbrecht, M., Gridel, G., Mosseri, V., Bouleuc, C., Poinsot, R., Vedrine, L., Ollivier, L., Garabige, V., et al. (2008) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/63.7.724 · Cited by 188
Chaïbi, P., Magné, N., Breton, S., Chebib, A., Watson, S., Duron, J.-J., Hannoun, L., Lefranc, J.-P., Piette, F., Menegaux, F., et al. (2011) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2010.08.004 · Cited by 184
Repetto, L., Biganzoli, L., Koehne, C. H., Luebbe, A. S., Soubeyran, P., Tjan-Heijnen, V. C. G., & Aapro, M. S. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(03)00662-2 · Cited by 174
Comprehensive Geriatric assessment and its clinical impact in oncology
Maas, H. A. A. M., Janssen-Heijnen, M. L. G., Olde Rikkert, M. G. M., & Machteld Wymenga, A. N. (2007) · European Journal of Cancer · doi:10.1016/j.ejca.2007.08.002 · Cited by 172
Hamaker, M. E., Vos, A. G., Smorenburg, C. H., Rooij, S. E., & Munster, B. C. (2012) · The Oncologist · doi:10.1634/theoncologist.2012-0186 · Cited by 167
Predictors of tolerance to chemotherapy in older cancer patients
Extermann, M., Chen, H., Cantor, A. B., Corcoran, M. B., Meyer, J. S., Grendys, E. C., Cavanaugh, D., Antonek, S., Camarata, A., Haley, W. E., et al. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00090-4 · Cited by 157
Hurria, A., Lichtman, S. M., Gardes, J., Li, D., Limaye, S. A., Patil, S., Zuckerman, E. L., Tew, W. P., Hamlin, P. A., Abou‐Alfa, G. K., et al. (2007) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01367.x · Cited by 151
Tolerance to Chemotherapy in Elderly Patients with Cancer
Wedding, U., Honecker, F. U., Bokemeyer, C., Pientka, L., & Höffken, K. (2007) · Cancer Control · doi:10.1177/107327480701400106 · Cited by 97
The impact of low-grade toxicity in older people with cancer undergoing chemotherapy
Kalsi, T., Babic-Illman, G., Fields, P. A., Hughes, S. R., Maisey, N. R., Ross, P. J., Wang, Y., & Harari, D. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.496 · Cited by 73
Self-citationGeriatric Assessment in Elderly Patients with Prostate Cancer
Terret, C., Albrand, G., & Droz, J. P. (2004) · Clinical Prostate Cancer · doi:10.3816/cgc.2004.n.005 · Cited by 72
Basso, U., Tonti, S., Bassi, C., Brunello, A., Pasetto, L. M., Scaglione, D., Falci, C., Beda, M., Aversa, S. M. L., Stefani, M., et al. (2008) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2007.12.006 · Cited by 70
The Importance of Planned Dose of Chemotherapy on Time: Do We Need to Change Our Clinical Practice?
Foote, M. (1998) · The Oncologist · doi:10.1634/theoncologist.3-5-365 · Cited by 70
Age, comorbidity, treatment decision and prognosis in lung cancer
Blanco, J. A. G., Toste, I. S., Álvarez, R. F., Cuadrado, G. R., Gonzálvez, A. M., & Martin, I. J. G. (2008) · Age and Ageing · doi:10.1093/ageing/afn226 · Cited by 67
Marenco, D., Marinello, R., Berruti, A., Gaspari, F., Stasi, M. F., Rosato, R., Bertetto, O., Molaschi, M., & Ciccone, G. (2008) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2008.07.003 · Cited by 54
Are the UK oncology trainees adequately informed about the needs of older people with cancer?
Kalsi, T., Payne, S., Brodie, H., Mansi, J., Wang, Y., & Harari, D. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.204 · Cited by 48
Self-citationACCO: ASCO Core Curriculum Outline
Muss, H. B., Roenn, J. V., Damon, L. E., DeAngelis, L. M., Flaherty, L. E., Harari, P. M., Kelly, K. L., Kosty, M. P., Loscalzo, M. J., Mennel, R. G., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.99.008 · Cited by 33
Collaboration with Orthopaedic Surgeons
Elliot, J. R., WILKINSON, T. J., Hanger, H. C., Gilchrist, N. L., SAINSBURY, R., Shamy, S., & Rothwell, A. G. (1996) · Age and Ageing · doi:10.1093/ageing/25.3.259 · Cited by 11
Collaboration with Orthopaedic Surgeons
ELLIOT, J. R., WILKINSON, T. J., Hanger, H. C., Gilchrist, N. L., Sainsbury, R., Shamy, S., & Rothwell, A. G. (1996) · Age and Ageing · doi:10.1093/ageing/25.5.414 · Cited by 8
Diagnostic Criteria for Vascular Dementia
Hillam, J. C., & Graham, N. (1996) · Age and Ageing · doi:10.1093/ageing/25.5.414-a · Cited by 7
Cited by
The impact of comorbidity on cancer and its treatment
Sarfati, D., Koczwara, B., & Jackson, C. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21342 · Cited by 680
Global cancer incidence in older adults, 2012 and 2035: A population‐based study
Pilleron, S., Sarfati, D., Janssen‐Heijnen, M., Vignat, J., Ferlay, J., Bray, F., & Soerjomataram, I. (2019) · International Journal of Cancer · doi:10.1002/ijc.31664 · Cited by 670
Gillessen, S., Attard, G., Beer, T. M., Beltran, H., Bossi, A., Bristow, R., Carver, B., Castellano, D., Chung, B. H., Clarke, N., et al. (2018) · European Urology · doi:10.1016/j.eururo.2017.06.002 · Cited by 642
Mohile, S. G., Mohamed, M. R., Xu, H., Culakova, E., Loh, K. P., Magnuson, A., Flannery, M. A., Obrecht, S., Gilmore, N., Ramsdale, E., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)01789-x · Cited by 602
The Multidisciplinary Team (MDT) Approach and Quality of Care
Taberna, M., Gil Moncayo, F., Jané-Salas, E., Antonio, M., Arribas, L., Vilajosana, E., Peralvez Torres, E., & Mesía, R. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00085 · Cited by 513
Metadata
- Authors
- Kalsi, T., Babic-Illman, G., Ross, P. J., Maisey, N. R., Hughes, S., Fields, P., Martin, F. C., Wang, Y., & Harari, D.
- Venue
- British Journal of Cancer
- Published
- 2015-04
- Volume
- 112
- Issue
- 9
- Pages
- 1435-1444
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2047503765
- Cited by
- 265
- References
- 35
- FWCI
- 11.55
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.